New initiative aims to transform how Alzheimer’s disease is diagnosed, treated across healthcare settings

Members of the AD-RIDDLE consortium announced today that they will begin a new initiative that aims to bridge the gap between Alzheimer’s research, implementation science, and precision medicine.

Pharmalittle: We’re reading about the FTC vs. PBMs, FDA adcomm voting and more

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After

February 28, 2024

Revance touts first therapeutic indication for Botox rival Daxxify in cervical dystonia

Revance Therapeutics secured an FDA approval on Monday for its Botox rival Daxxify in cervical dystonia, marking the drug’s first therapeutic indication. Daxxify was approved

August 15, 2023

Black people still experience highest burden of air pollution-related deaths

Health benefits that have resulted from reductions in fine particulate air pollution aren’t distributed equally among populations in the U.S., a new Yale-led study finds.

September 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.